Cite
HARVARD Citation
Haberman, R. et al. (2021). Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. Annals of the rheumatic diseases. 80 (10), pp. 1339-1344. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Haberman, R. et al. (2021). Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease. Annals of the rheumatic diseases. 80 (10), pp. 1339-1344. [Online].